The global Parkinsons Disease Drug market was valued at US$ 5492 million in 2023 and is anticipated to reach US$ 7419.9 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

Parkinsons Disease Drug Market

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Parkinsons Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinsons Disease Drug.

Report Scope

The Parkinsons Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parkinsons Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Parkinsons Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Parkinsons Disease Drug Market Report

Report Metric	Details
Report Name	Parkinsons Disease Drug Market
Accounted market size in 2023	US$ 5492 million
Forecasted market size in 2030	US$ 7419.9 million
CAGR	4.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Carbidopa/Levodopa Dopamine Receptor Agonists MAO-Inhibitors
Segment by Application	Hospital Clinics Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva, Novartis AG, GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, Sun Pharma, Wockhardt, UCB, Bausch Health, Acadia
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parkinsons Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parkinsons Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Parkinsons Disease Drug Market growing?

Ans: The Parkinsons Disease Drug Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Parkinsons Disease Drug Market size in 2030?

Ans: The Parkinsons Disease Drug Market size in 2030 will be US$ 7419.9 million.

Who are the main players in the Parkinsons Disease Drug Market report?

Ans: The main players in the Parkinsons Disease Drug Market are Teva, Novartis AG, GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, Sun Pharma, Wockhardt, UCB, Bausch Health, Acadia

What are the Application segmentation covered in the Parkinsons Disease Drug Market report?

Ans: The Applications covered in the Parkinsons Disease Drug Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Parkinsons Disease Drug Market report?

Ans: The Types covered in the Parkinsons Disease Drug Market report are Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors

1 Parkinsons Disease Drug Market Overview

1.1 Product Overview and Scope of Parkinsons Disease Drug

1.2 Parkinsons Disease Drug Segment by Type

1.2.1 Global Parkinsons Disease Drug Market Value Comparison by Type (2024-2030)

1.2.2 Carbidopa/Levodopa

1.2.3 Dopamine Receptor Agonists

1.2.4 MAO-Inhibitors

1.3 Parkinsons Disease Drug Segment by Application

1.3.1 Global Parkinsons Disease Drug Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Other

1.4 Global Parkinsons Disease Drug Market Size Estimates and Forecasts

1.4.1 Global Parkinsons Disease Drug Revenue 2019-2030

1.4.2 Global Parkinsons Disease Drug Sales 2019-2030

1.4.3 Global Parkinsons Disease Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Parkinsons Disease Drug Market Competition by Manufacturers

2.1 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Parkinsons Disease Drug Average Price by Manufacturers (2019-2024)

2.4 Global Parkinsons Disease Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Parkinsons Disease Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Parkinsons Disease Drug, Product Type & Application

2.7 Parkinsons Disease Drug Market Competitive Situation and Trends

2.7.1 Parkinsons Disease Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Parkinsons Disease Drug Players Market Share by Revenue

2.7.3 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Parkinsons Disease Drug Retrospective Market Scenario by Region

3.1 Global Parkinsons Disease Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Parkinsons Disease Drug Global Parkinsons Disease Drug Sales by Region: 2019-2030

3.2.1 Global Parkinsons Disease Drug Sales by Region: 2019-2024

3.2.2 Global Parkinsons Disease Drug Sales by Region: 2025-2030

3.3 Global Parkinsons Disease Drug Global Parkinsons Disease Drug Revenue by Region: 2019-2030

3.3.1 Global Parkinsons Disease Drug Revenue by Region: 2019-2024

3.3.2 Global Parkinsons Disease Drug Revenue by Region: 2025-2030

3.4 North America Parkinsons Disease Drug Market Facts & Figures by Country

3.4.1 North America Parkinsons Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Parkinsons Disease Drug Sales by Country (2019-2030)

3.4.3 North America Parkinsons Disease Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Parkinsons Disease Drug Market Facts & Figures by Country

3.5.1 Europe Parkinsons Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Parkinsons Disease Drug Sales by Country (2019-2030)

3.5.3 Europe Parkinsons Disease Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Parkinsons Disease Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Parkinsons Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Parkinsons Disease Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Parkinsons Disease Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Parkinsons Disease Drug Market Facts & Figures by Country

3.7.1 Latin America Parkinsons Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Parkinsons Disease Drug Sales by Country (2019-2030)

3.7.3 Latin America Parkinsons Disease Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Parkinsons Disease Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Parkinsons Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Parkinsons Disease Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Parkinsons Disease Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Parkinsons Disease Drug Sales by Type (2019-2030)

4.1.1 Global Parkinsons Disease Drug Sales by Type (2019-2024)

4.1.2 Global Parkinsons Disease Drug Sales by Type (2025-2030)

4.1.3 Global Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

4.2 Global Parkinsons Disease Drug Revenue by Type (2019-2030)

4.2.1 Global Parkinsons Disease Drug Revenue by Type (2019-2024)

4.2.2 Global Parkinsons Disease Drug Revenue by Type (2025-2030)

4.2.3 Global Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

4.3 Global Parkinsons Disease Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Parkinsons Disease Drug Sales by Application (2019-2030)

5.1.1 Global Parkinsons Disease Drug Sales by Application (2019-2024)

5.1.2 Global Parkinsons Disease Drug Sales by Application (2025-2030)

5.1.3 Global Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

5.2 Global Parkinsons Disease Drug Revenue by Application (2019-2030)

5.2.1 Global Parkinsons Disease Drug Revenue by Application (2019-2024)

5.2.2 Global Parkinsons Disease Drug Revenue by Application (2025-2030)

5.2.3 Global Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

5.3 Global Parkinsons Disease Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Teva

6.1.1 Teva Corporation Information

6.1.2 Teva Description and Business Overview

6.1.3 Teva Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Teva Parkinsons Disease Drug Product Portfolio

6.1.5 Teva Recent Developments/Updates

6.2 Novartis AG

6.2.1 Novartis AG Corporation Information

6.2.2 Novartis AG Description and Business Overview

6.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Novartis AG Parkinsons Disease Drug Product Portfolio

6.2.5 Novartis AG Recent Developments/Updates

6.3 GSK

6.3.1 GSK Corporation Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GSK Parkinsons Disease Drug Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 AbbVie

6.4.1 AbbVie Corporation Information

6.4.2 AbbVie Description and Business Overview

6.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 AbbVie Parkinsons Disease Drug Product Portfolio

6.4.5 AbbVie Recent Developments/Updates

6.5 Merck

6.5.1 Merck Corporation Information

6.5.2 Merck Description and Business Overview

6.5.3 Merck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Merck Parkinsons Disease Drug Product Portfolio

6.5.5 Merck Recent Developments/Updates

6.6 Boehringer Ingelheim

6.6.1 Boehringer Ingelheim Corporation Information

6.6.2 Boehringer Ingelheim Description and Business Overview

6.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Boehringer Ingelheim Parkinsons Disease Drug Product Portfolio

6.6.5 Boehringer Ingelheim Recent Developments/Updates

6.7 Impax Laboratories

6.6.1 Impax Laboratories Corporation Information

6.6.2 Impax Laboratories Description and Business Overview

6.6.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Impax Laboratories Parkinsons Disease Drug Product Portfolio

6.7.5 Impax Laboratories Recent Developments/Updates

6.8 Lundbeck

6.8.1 Lundbeck Corporation Information

6.8.2 Lundbeck Description and Business Overview

6.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Lundbeck Parkinsons Disease Drug Product Portfolio

6.8.5 Lundbeck Recent Developments/Updates

6.9 Sun Pharma

6.9.1 Sun Pharma Corporation Information

6.9.2 Sun Pharma Description and Business Overview

6.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sun Pharma Parkinsons Disease Drug Product Portfolio

6.9.5 Sun Pharma Recent Developments/Updates

6.10 Wockhardt

6.10.1 Wockhardt Corporation Information

6.10.2 Wockhardt Description and Business Overview

6.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Wockhardt Parkinsons Disease Drug Product Portfolio

6.10.5 Wockhardt Recent Developments/Updates

6.11 UCB

6.11.1 UCB Corporation Information

6.11.2 UCB Parkinsons Disease Drug Description and Business Overview

6.11.3 UCB Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 UCB Parkinsons Disease Drug Product Portfolio

6.11.5 UCB Recent Developments/Updates

6.12 Bausch Health

6.12.1 Bausch Health Corporation Information

6.12.2 Bausch Health Parkinsons Disease Drug Description and Business Overview

6.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Bausch Health Parkinsons Disease Drug Product Portfolio

6.12.5 Bausch Health Recent Developments/Updates

6.13 Acadia

6.13.1 Acadia Corporation Information

6.13.2 Acadia Parkinsons Disease Drug Description and Business Overview

6.13.3 Acadia Parkinsons Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Acadia Parkinsons Disease Drug Product Portfolio

6.13.5 Acadia Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Parkinsons Disease Drug Industry Chain Analysis

7.2 Parkinsons Disease Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Parkinsons Disease Drug Production Mode & Process

7.4 Parkinsons Disease Drug Sales and Marketing

7.4.1 Parkinsons Disease Drug Sales Channels

7.4.2 Parkinsons Disease Drug Distributors

7.5 Parkinsons Disease Drug Customers

8 Parkinsons Disease Drug Market Dynamics

8.1 Parkinsons Disease Drug Industry Trends

8.2 Parkinsons Disease Drug Market Drivers

8.3 Parkinsons Disease Drug Market Challenges

8.4 Parkinsons Disease Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Parkinsons Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Parkinsons Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Parkinsons Disease Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Parkinsons Disease Drug Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Parkinsons Disease Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Parkinsons Disease Drug Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Parkinsons Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Parkinsons Disease Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Parkinsons Disease Drug, Product Type & Application

Table 12. Global Key Manufacturers of Parkinsons Disease Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Parkinsons Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Parkinsons Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Parkinsons Disease Drug Sales by Region (2019-2024) & (K Doses)

Table 18. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2024)

Table 19. Global Parkinsons Disease Drug Sales by Region (2025-2030) & (K Doses)

Table 20. Global Parkinsons Disease Drug Sales Market Share by Region (2025-2030)

Table 21. Global Parkinsons Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Parkinsons Disease Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Parkinsons Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Parkinsons Disease Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Parkinsons Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Parkinsons Disease Drug Sales by Country (2019-2024) & (K Doses)

Table 27. North America Parkinsons Disease Drug Sales by Country (2025-2030) & (K Doses)

Table 28. North America Parkinsons Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Parkinsons Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Parkinsons Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Parkinsons Disease Drug Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Parkinsons Disease Drug Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Parkinsons Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Parkinsons Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Parkinsons Disease Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Parkinsons Disease Drug Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Parkinsons Disease Drug Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Parkinsons Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Parkinsons Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Parkinsons Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Parkinsons Disease Drug Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Parkinsons Disease Drug Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Parkinsons Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Parkinsons Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Parkinsons Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Parkinsons Disease Drug Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Parkinsons Disease Drug Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Parkinsons Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Parkinsons Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Parkinsons Disease Drug Sales (K Doses) by Type (2019-2024)

Table 51. Global Parkinsons Disease Drug Sales (K Doses) by Type (2025-2030)

Table 52. Global Parkinsons Disease Drug Sales Market Share by Type (2019-2024)

Table 53. Global Parkinsons Disease Drug Sales Market Share by Type (2025-2030)

Table 54. Global Parkinsons Disease Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Parkinsons Disease Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Parkinsons Disease Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Parkinsons Disease Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Parkinsons Disease Drug Price (USD/Dose) by Type (2019-2024)

Table 59. Global Parkinsons Disease Drug Price (USD/Dose) by Type (2025-2030)

Table 60. Global Parkinsons Disease Drug Sales (K Doses) by Application (2019-2024)

Table 61. Global Parkinsons Disease Drug Sales (K Doses) by Application (2025-2030)

Table 62. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2024)

Table 63. Global Parkinsons Disease Drug Sales Market Share by Application (2025-2030)

Table 64. Global Parkinsons Disease Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Parkinsons Disease Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Parkinsons Disease Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Parkinsons Disease Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Parkinsons Disease Drug Price (USD/Dose) by Application (2019-2024)

Table 69. Global Parkinsons Disease Drug Price (USD/Dose) by Application (2025-2030)

Table 70. Teva Corporation Information

Table 71. Teva Description and Business Overview

Table 72. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Teva Parkinsons Disease Drug Product

Table 74. Teva Recent Developments/Updates

Table 75. Novartis AG Corporation Information

Table 76. Novartis AG Description and Business Overview

Table 77. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. Novartis AG Parkinsons Disease Drug Product

Table 79. Novartis AG Recent Developments/Updates

Table 80. GSK Corporation Information

Table 81. GSK Description and Business Overview

Table 82. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. GSK Parkinsons Disease Drug Product

Table 84. GSK Recent Developments/Updates

Table 85. AbbVie Corporation Information

Table 86. AbbVie Description and Business Overview

Table 87. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. AbbVie Parkinsons Disease Drug Product

Table 89. AbbVie Recent Developments/Updates

Table 90. Merck Corporation Information

Table 91. Merck Description and Business Overview

Table 92. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. Merck Parkinsons Disease Drug Product

Table 94. Merck Recent Developments/Updates

Table 95. Boehringer Ingelheim Corporation Information

Table 96. Boehringer Ingelheim Description and Business Overview

Table 97. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Boehringer Ingelheim Parkinsons Disease Drug Product

Table 99. Boehringer Ingelheim Recent Developments/Updates

Table 100. Impax Laboratories Corporation Information

Table 101. Impax Laboratories Description and Business Overview

Table 102. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. Impax Laboratories Parkinsons Disease Drug Product

Table 104. Impax Laboratories Recent Developments/Updates

Table 105. Lundbeck Corporation Information

Table 106. Lundbeck Description and Business Overview

Table 107. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 108. Lundbeck Parkinsons Disease Drug Product

Table 109. Lundbeck Recent Developments/Updates

Table 110. Sun Pharma Corporation Information

Table 111. Sun Pharma Description and Business Overview

Table 112. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 113. Sun Pharma Parkinsons Disease Drug Product

Table 114. Sun Pharma Recent Developments/Updates

Table 115. Wockhardt Corporation Information

Table 116. Wockhardt Description and Business Overview

Table 117. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 118. Wockhardt Parkinsons Disease Drug Product

Table 119. Wockhardt Recent Developments/Updates

Table 120. UCB Corporation Information

Table 121. UCB Description and Business Overview

Table 122. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 123. UCB Parkinsons Disease Drug Product

Table 124. UCB Recent Developments/Updates

Table 125. Bausch Health Corporation Information

Table 126. Bausch Health Description and Business Overview

Table 127. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 128. Bausch Health Parkinsons Disease Drug Product

Table 129. Bausch Health Recent Developments/Updates

Table 130. Acadia Corporation Information

Table 131. Acadia Description and Business Overview

Table 132. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 133. Acadia Parkinsons Disease Drug Product

Table 134. Acadia Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Parkinsons Disease Drug Distributors List

Table 138. Parkinsons Disease Drug Customers List

Table 139. Parkinsons Disease Drug Market Trends

Table 140. Parkinsons Disease Drug Market Drivers

Table 141. Parkinsons Disease Drug Market Challenges

Table 142. Parkinsons Disease Drug Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Parkinsons Disease Drug

Figure 2. Global Parkinsons Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Parkinsons Disease Drug Market Share by Type in 2023 & 2030

Figure 4. Carbidopa/Levodopa Product Picture

Figure 5. Dopamine Receptor Agonists Product Picture

Figure 6. MAO-Inhibitors Product Picture

Figure 7. Global Parkinsons Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Parkinsons Disease Drug Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinics

Figure 11. Other

Figure 12. Global Parkinsons Disease Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Parkinsons Disease Drug Market Size (2019-2030) & (US$ Million)

Figure 14. Global Parkinsons Disease Drug Sales (2019-2030) & (K Doses)

Figure 15. Global Parkinsons Disease Drug Average Price (USD/Dose) & (2019-2030)

Figure 16. Parkinsons Disease Drug Report Years Considered

Figure 17. Parkinsons Disease Drug Sales Share by Manufacturers in 2023

Figure 18. Global Parkinsons Disease Drug Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Parkinsons Disease Drug Players: Market Share by Revenue in 2023

Figure 20. Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Parkinsons Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Parkinsons Disease Drug Sales Market Share by Country (2019-2030)

Figure 23. North America Parkinsons Disease Drug Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Parkinsons Disease Drug Sales Market Share by Country (2019-2030)

Figure 27. Europe Parkinsons Disease Drug Revenue Market Share by Country (2019-2030)

Figure 28. Germany Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Parkinsons Disease Drug Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Parkinsons Disease Drug Revenue Market Share by Region (2019-2030)

Figure 35. China Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Parkinsons Disease Drug Sales Market Share by Country (2019-2030)

Figure 46. Latin America Parkinsons Disease Drug Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Parkinsons Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Parkinsons Disease Drug by Type (2019-2030)

Figure 56. Global Revenue Market Share of Parkinsons Disease Drug by Type (2019-2030)

Figure 57. Global Parkinsons Disease Drug Price (USD/Dose) by Type (2019-2030)

Figure 58. Global Sales Market Share of Parkinsons Disease Drug by Application (2019-2030)

Figure 59. Global Revenue Market Share of Parkinsons Disease Drug by Application (2019-2030)

Figure 60. Global Parkinsons Disease Drug Price (USD/Dose) by Application (2019-2030)

Figure 61. Parkinsons Disease Drug Value Chain

Figure 62. Parkinsons Disease Drug Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions